Trials / Completed
CompletedNCT00946764
To Demonstrate the Relative Bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions
Comparative, Randomized, Single-Dose, 2-way Crossover Bioavailability Study of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg Imipramine Hydrochloride Tablets In Healthy Adults Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 19 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Sandoz Inc. and Tyco Healthcare (Tofranil) 50 mg imipramine hydrochloride tablets in healthy adult volunteers under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Imipramine Hydrochloride 50 mg Tablets (Sandoz Inc.) | |
| DRUG | Tofranil Imipramine Hydrochloride 50 mg Tablets (Tyco Healthcare) |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2005-09-01
- Completion
- 2005-09-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946764. Inclusion in this directory is not an endorsement.